Neuropathic pain. Epilepsy. Generalized anxiety disorder. Fibromyalgia.

Gastroduodenal ulcer, gastritis, including those caused by Helicobacter pylori (as part of schemes of Helicobacter therapy); chronic gastritis and gastroduodenitis in the acute phase, including those caused by Helicobacter pylori.

Taking into account the limited gentamicin therapeutic range, the drug should be used in those cases when microorganisms are resistant to other antibiotics. Gentamicin sulfate is indicated for the treatment of infections due to pathogens susceptible to the drug, including: septicemia; urinary tract infection; lower respiratory tract diseases; infections of skin, bones, soft tissue, infected burning wounds; CNS infections (meningitis) in combination with β-lactam antibiotics; peritoneal infection (peritonitis).

For the treatment of infections caused by microorganisms sensitive to cefoperazone: infections of the upper and lower respiratory tract; infections of the upper and lower parts of the urinary tract; peritonitis, cholecystitis, cholangitis and other intra-abdominal infections; septicemia; meningitis; infections of skin and soft tissues; infections of bones and joints; pelvic inflammatory disease, endometritis, gonorrhea and other genital tract infections.

Treatment of infections caused by microorganisms sensitive to the drug: respiratory tract infections (upper and lower); urinary tract infections (upper and lower); peritonitis, cholecystitis, cholangitis and other infections of the abdominal cavity; septicemia; meningitis; infections of skin and soft tissues; infections of bones and joints; inflammatory pelvic disease, endometritis, gonorrhea and other infections of genital organs.

Functional and organic diseases of the nervous system (neurosis, neurosis states, vegetovascular dystonia, the effects neuroinfections, traumatic brain injury, perinatal and other forms of encephalopathy, including alcoholic genesis), accompanied by increased excitability, emotional instability, decreased mental capacity, sleep disorders. Ischemic stroke and cerebrovascular diseases. As an additional means in treatment of alcoholism.

Treatment of adult patients with Type II diabetes.

As monotherapy:

— for patients whose diet and exercise alone does not provide adequate control, and for patients for whom metformin use is considered inappropriate due to the presence of contraindications or intolerance.

As part of the dual oral therapy in combination with:

— metformin in patients with insufficient glycemic control, despite the use of the maximum tolerated dose when monotherapy with metformin;

— sulfonylurea in patients with insufficient glycemic control, despite the use of the maximum tolerated dose of sulfonylurea, and in patients for whom metformin is considered inappropriate due to the presence of contraindications or intolerance;

— thiazolidinedione for patients with insufficient glycemic control, for which thiazolidinedione is considered acceptable.

As part of triple oral therapy in combination with:

— sulfonylurea and metformin when diet and exercise with dual therapy with these drugs do not provide adequate glycemic control. In combination with insulin (with or without metformin), when a diet and physical exercise together with a stable insulin dose do not provide adequate glycemic control.

Infections caused by gram-positive bacteria, including sensitive or resistant to methicillin and patients with allergy to beta-lactam antibiotics. Infections of skin and soft tissues; infections of the upper and lower urinary tract complications with or without; respiratory tract infections; infections of ear, nose and throat; bone and joint infections; septicemia; endocarditis; peritonitis associated with permanent peritoneal dialysis in ambulatory terms. Prevention: prevention of infective endocarditis in case of allergy to beta-lactam antibiotics: in stomatology or during procedures in the upper respiratory tract that are used under general anesthesia; under surgery interference on genitourinary and digestive tract. Childrens (except newborns). Treatment: infections of skin and soft tissues; infections of the upper and lower urinary tract complications with or without; respiratory tract infections; infections of ear, nose and throat; bone and joint infections; septicemia.